Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency
It has been reported that mismatch repair deficient (d-MMR) tumors show sensitivity to immune checkpoint inhibitors. We aimed to evaluate the correlation of d-MMR and PD-1/PD-L1 expression in invasive urothelial carcinoma of the bladder. Tissue microarray (TMA) tissues were stained PD-1/PD-L1 and MM...
Main Authors: | Nuran Sungu, Merve M. Kıran |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2023-10-01
|
Series: | Polish Journal of Pathology |
Subjects: | |
Online Access: | https://www.termedia.pl/Status-of-PD-1-and-PD-L1-expression-in-invasive-urothelial-carcinoma-of-the-bladder-with-mismatch-repair-protein-deficiency,55,51678,1,1.html |
Similar Items
-
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study
by: Yu-Ting Ma, et al.
Published: (2023-11-01) -
Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
by: Utpal Kumar, et al.
Published: (2022-06-01) -
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
by: Randy F. Sweis, et al.
Published: (2018-04-01) -
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection
by: Enrico Munari, et al.
Published: (2022-07-01) -
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
by: Veronika Weyerer, et al.
Published: (2021-05-01)